Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Biogen Inc.
  6. News
  7. Summary
    BIIB   US09062X1037

BIOGEN INC.

(BIIB)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 10/25 04:55:18 pm
269.485 USD   +1.77%
10/22BIOGEN : Canaccord Genuity Adjusts Biogen PT to $390 From $423, Maintains Buy Rating
MT
10/22BB BIOTECH AG : BB Biotech: i ricavi -2-
DJ
10/22PRESS RELEASE : BB Biotech: Gains realized -2-
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Biogen : UBS Adjusts Biogen PT to $442 From $475, Maintains Buy Rating

09/16/2021 | 09:57am EDT


ę MT Newswires 2021
All news about BIOGEN INC.
10/22BIOGEN : Canaccord Genuity Adjusts Biogen PT to $390 From $423, Maintains Buy Rating
MT
10/22BB BIOTECH AG : BB Biotech: i ricavi -2-
DJ
10/22PRESS RELEASE : BB Biotech: Gains realized -2-
DJ
10/21BIOGEN : UBS Adjusts Price Target on Biogen to $406 From $405, Maintains Buy Rating
MT
10/21BIOGEN : Cowen Adjusts Biogen PT to $375 From $450, Maintains Outperform Rating
MT
10/21BIOGEN : JPMorgan Adjusts Biogen's Price Target to $324 From $425, Maintains Neutral Ratin..
MT
10/21BIOGEN : Morgan Stanley Adjusts Biogen's Price Target to $440 From $447, Maintains Overwei..
MT
10/21BIOGEN : Oppenheimer Adjusts Price Target on Biogen to $390 from $450, Keeps Outperform Ra..
MT
10/21BIOGEN : Needham Adjusts Price Target on Biogen to $386 from $398, Keeps Buy Rating
MT
10/21BIOGEN : RBC Cuts Price Target on Biogen to $295 From $325, Maintains Sector Perform Ratin..
MT
More news
Analyst Recommendations on BIOGEN INC.
More recommendations
Financials (USD)
Sales 2021 10 879 M - -
Net income 2021 1 657 M - -
Net Debt 2021 2 311 M - -
P/E ratio 2021 25,2x
Yield 2021 -
Capitalization 40 230 M 40 230 M -
EV / Sales 2021 3,91x
EV / Sales 2022 3,67x
Nbr of Employees 9 100
Free-Float 85,5%
Chart BIOGEN INC.
Duration : Period :
Biogen Inc. Technical Analysis Chart | BIIB | US09062X1037 | MarketScreener
Technical analysis trends BIOGEN INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 31
Last Close Price 269,94 $
Average target price 369,35 $
Spread / Average Target 36,8%
EPS Revisions
Managers and Directors
Michel Vounatsos Chief Executive Officer & Director
Michael R. McDonnell Chief Financial Officer & Executive Vice President
Stelios Papadopoulos Chairman
Alfred W. Sandrock Executive Vice President-Research & Development
Mark Hernon Chief Information Officer & Senior Vice President
Sector and Competitors